Liquid Biopsy and Concurrent Testing Strategies for Patients with Metastatic NSCLC

Why Should You Watch This Webinar?

• Hear a national thought leader discuss the impact of liquid biopsy and concurrent biomarker testing for the appropriate care of patients with NSCLC
• Brought to you by: CAP TODAY
• Moderated by: Bob McGonnagle, Publisher, CAP TODAY
• Presenter: Zin Htway, PhD, MBA

Program Objectives

• Discuss impact of biomarket testing for appropriate care of patiens with NSCLC
• Review potential benefits of integrating liquid biopsy with standard-of-care tissue testing on turnaround time and identification of patients with actionable biomarkers in metastatic NSCLC
• Explore patient case scenarios that demonstrate potential successes and implementation considerations for concurrent liquid biopsy integration in metastatic NSCLC

FEATURED SPEAKER:

Zin Htway, PhD, MBA

Supervisor and Operations Manager
Anatomic Pathology at HCA
Los Robles Hospital and Medical Center

Apr 11, 2024 | 12:00 PM ET

Liquid Biopsy and Concurrent Testing Strategies for Patients with Metastatic NSCLC

---

MODERATOR:

Bob McGonnagle

Publisher
CAP TODAY